tirzepatide deaths (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https GROUNDBREAKING UPDATE! FDA has approved

On the Oikos website, Oikos Fusion drinks are touted as: designed to help build and retain muscle mass during weight loss. [Oikos Fusion] is the first and only product in the yogurt category specifically created and positioned to support the unique nutrition needs of GLP-1 users and other weight loss consumers. The Danone growth strategy is twofold, therefore: they are making sure consumers know some existing products and brands are GLP-1 friendly, and also creating new products targeted at GLP-1 users

The elimination of this medication is very similar for both the oral and injectable form [25, 29]

Increase physical activity as tolerance improves

Underlying structural differences will affect modelled cost-effectiveness outcomes to some extent